Quarterly report pursuant to Section 13 or 15(d)

Consolidated Statements of Changes in Stockholders' Equity (Deficit)

v3.20.1
Consolidated Statements of Changes in Stockholders' Equity (Deficit) - USD ($)
Common Stock [Member]
Additional Paid-in Capital
Accumulated Deficit
Total
Balance at the beginning of the period at Sep. 30, 2018 $ 159,815 $ 35,517,491 $ (34,317,478) $ 1,359,828
Balance at the beginning of the period (in shares) at Sep. 30, 2018 159,815,013      
Net Income loss $ 0 0 (2,430,275) (2,430,275)
Shares issued for the exercise of stock options - cashless $ 477 (477) 0 0
Shares issued for the exercise of stock options - cashless (in shares) 477,269      
Shares issued for the exercise of stock options $ 88 32,312 0 32,400
Shares issued for the exercise of stock options (in shares) 87,567      
Issuance of restricted stock $ 3,517 (3,517) 0 0
Issuance of restricted stock (in shares) 3,517,000      
Issuance of restricted stock for services $ 50 21,450 0 21,500
Issuance of restricted stock for services (in shares) 50,000      
Stock based compensation expense $ 0 815,614 0 815,614
Balance at the ending of the period at Mar. 31, 2019 $ 163,947 36,382,873 (36,747,753) (200,933)
Balance at the ending of the period (in shares) at Mar. 31, 2019 163,946,849      
Balance at the beginning of the period at Dec. 31, 2018 $ 162,197 36,091,446 (36,917,715) (664,072)
Balance at the beginning of the period (in shares) at Dec. 31, 2018 162,196,849      
Net Income loss $ 0 0 169,962 169,962
Issuance of restricted stock $ 1,750 (1,750) 0 0
Issuance of restricted stock (in shares) 1,750,000      
Stock based compensation expense $ 0 293,177 0 293,177
Balance at the ending of the period at Mar. 31, 2019 $ 163,947 36,382,873 (36,747,753) (200,933)
Balance at the ending of the period (in shares) at Mar. 31, 2019 163,946,849      
Balance at the beginning of the period at Sep. 30, 2019 $ 172,612 37,885,151 (38,865,060) $ (807,297)
Balance at the beginning of the period (in shares) at Sep. 30, 2019 172,612,233     173,577,233
Net Income loss $ 0 0 (2,391,638) $ (2,391,638)
Issuance of common stock and warrants, net of financing costs $ 14,286 2,152,876 0 2,167,162
Issuance of common stock and warrants, net of financing costs (in shares) 14,285,714      
Stock based compensation expense $ 0 496,255 0 496,255
Balance at the ending of the period at Mar. 31, 2020 $ 186,898 40,534,282 (41,256,698) $ (535,518)
Balance at the ending of the period (in shares) at Mar. 31, 2020 186,897,947     187,862,947
Balance at the beginning of the period at Dec. 31, 2019 $ 186,898 40,237,079 (40,524,814) $ (100,837)
Balance at the beginning of the period (in shares) at Dec. 31, 2019 186,897,947      
Net Income loss $ 0 0 (731,884) (731,884)
Stock based compensation expense 0 297,203 0 297,203
Balance at the ending of the period at Mar. 31, 2020 $ 186,898 $ 40,534,282 $ (41,256,698) $ (535,518)
Balance at the ending of the period (in shares) at Mar. 31, 2020 186,897,947     187,862,947